SHOCKWAVE MEDICAL INC (SWAV)

US82489T1043 - Common Stock

328.87  +0.33 (+0.1%)

After market: 328.87 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to SWAV. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 322.46. This target is -1.95% below the current price.
SWAV was analyzed by 17 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about SWAV.
In the previous month the buy percentage consensus was at a similar level.
SWAV was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 328.87212.10341.70322.46386.40 - -35.51% 3.90% -1.95% 17.49%
Up and Down Grades
Date Firm Action Rating
2024-04-08 Leerink Partners Downgrade Outperform -> Market Perform
2024-04-08 CL King Downgrade Buy -> Neutral
2024-04-08 Deutsche Bank Downgrade Buy -> Hold
2024-04-08 Morgan Stanley Downgrade Overweight -> Equal-Weight
2024-04-05 Wolfe Research Downgrade Outperform -> Peer Perform
2024-04-05 Needham Downgrade Buy -> Hold
2024-04-05 Canaccord Genuity Downgrade Buy -> Hold
2024-04-02 Piper Sandler Maintains Overweight -> Overweight
2024-03-27 CL King Initiate Buy
2024-02-16 Needham Maintains Buy -> Buy
2024-02-16 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2024-02-16 Piper Sandler Maintains Overweight -> Overweight
2023-12-04 Morgan Stanley Maintains Overweight -> Overweight
2023-11-07 Needham Maintains Buy -> Buy
2023-11-07 Morgan Stanley Maintains Overweight -> Overweight
2023-10-24 Needham Maintains Buy -> Buy
2023-10-16 Leerink Partners Initiate Outperform
2023-09-29 UBS Initiate Neutral
2023-08-10 Morgan Stanley Maintains Overweight -> Overweight
2023-08-08 Needham Maintains Buy -> Buy
2023-08-08 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2023-07-10 Morgan Stanley Upgrade Equal-Weight -> Overweight
2023-05-09 Deutsche Bank Maintains Buy
2023-05-09 Needham Maintains Buy
2023-05-09 Oppenheimer Reiterate Underperform
2023-05-09 Wells Fargo Maintains Equal-Weight
2023-05-09 Canaccord Genuity Maintains Buy
2023-05-09 Morgan Stanley Maintains Equal-Weight
2023-05-09 Piper Sandler Maintains Overweight
2023-04-11 Needham Maintains Buy